| 000 | 01711 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513153025.0 | ||
| 264 | 0 | _c19981103 | |
| 008 | 199811s 0 0 eng d | ||
| 022 | _a0008-5472 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSarkaria, J N | |
| 245 | 0 | 0 |
_aInhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin. _h[electronic resource] |
| 260 |
_bCancer research _cOct 1998 |
||
| 300 |
_a4375-82 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdenocarcinoma |
| 650 | 0 | 4 |
_aAndrostadienes _xpharmacology |
| 650 | 0 | 4 | _aAtaxia Telangiectasia Mutated Proteins |
| 650 | 0 | 4 |
_aCell Cycle _xdrug effects |
| 650 | 0 | 4 | _aCell Cycle Proteins |
| 650 | 0 | 4 |
_aDNA, Neoplasm _xbiosynthesis |
| 650 | 0 | 4 | _aDNA-Activated Protein Kinase |
| 650 | 0 | 4 | _aDNA-Binding Proteins |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aG2 Phase |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 | _aLung Neoplasms |
| 650 | 0 | 4 | _aNuclear Proteins |
| 650 | 0 | 4 | _aPhosphoinositide-3 Kinase Inhibitors |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aRadiation-Sensitizing Agents _xpharmacology |
| 650 | 0 | 4 | _aS Phase |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 650 | 0 | 4 | _aTumor Suppressor Proteins |
| 650 | 0 | 4 | _aWortmannin |
| 700 | 1 | _aTibbetts, R S | |
| 700 | 1 | _aBusby, E C | |
| 700 | 1 | _aKennedy, A P | |
| 700 | 1 | _aHill, D E | |
| 700 | 1 | _aAbraham, R T | |
| 773 | 0 |
_tCancer research _gvol. 58 _gno. 19 _gp. 4375-82 |
|
| 999 |
_c9731481 _d9731481 |
||